Table 1.
Relevant laboratory parameters.
| Parameter | Value |
|---|---|
| Haemoglobin | 15, 9 (13, 5–18 g/dl |
| Leucocytes/neutrophils | 13300 (4–10) mm3; 60, 7% (37–72) |
| C reactive protein | 2, 7 (<1) mg/dl |
| ESR | 22 (1–20) mm/1st h |
| Antithrombin III | 96% (80–120) |
| Protein C | 101% (70–140) |
| Protein S | 111, 5% (64–129) |
| Factor V Leiden | Negative |
| Homocysteine | 7, 61 (<15) µmol/l |
| Lupus anticoagulant | Negative: 1, 16 (0, 8–1, 2) R |
| Anticardiolipin | IgM-6 (<7) MPL; IgG-10 (<10) GPL |
| ANA | Negative (<1/160) |
| DNA ds | Negative (<1/10) |
| A-SSA | 0.1 (<40) U/ml |
| A-SSB | 0, 1 (<40) U/ml |
| A-SM/RNP | 0, 1 (<40) U/ml |
| A-SM | 0, 1 (<40) U/ml |
| A-Centromere | 0, 1 (<40) U/ml |
| A-SCL70 | 0, 1 (<40) U/ml |
| ANCA-C | 0, 1 (<25) U/ml |
| ANCA-P | 0, 1 (<25) U/ml |
| C3 | 161 (75–140) mg/dl |
| C4 | 38, 8 (10–34) mg/dl |
| C1q | 13, 24 (8–15) mg/dl |
| Circulating immunocomplexes | 1, 6 (<10, 8) µg/dl |
ANA, antinuclear antibody; ANCA, antineutrophil cytoplasmic antibodies; A-SCL, antiscleroderma; A-SSA, anti Sjögren’s syndrome A; A-SSB, anti Sjögren’s syndrome B; ESR, erythrocyte sedimentation rate; MPL, IgM phospholipid units; GPL, IgG phospholipid units; SM/RNP, Smith/Ribonucleoprotein.